Organization
Scipher Medicine Corporation
2 abstracts
Abstract
A MOLECULAR SIGNATURE RESPONSE CLASSIFIER PREDICTS THE LIKELIHOOD OF EULAR NON-RESPONSE TO TNF INHIBITOR THERAPIES IN RA: RESULTS FROM A RETROSPECTIVE COHORT ANALYSISOrg: Scipher Medicine Corporation, Sint Maartenskliniek,
Abstract
ASSESSMENT OF CLINICAL FEATURES AS PREDICTORS OF INADEQUATE RESPONSE TO TNFI THERAPIES—FURTHER ANALYSIS OF THE MOLECULAR SIGNATURE RESPONSE CLASSIFIEROrg: Scipher Medicine Corporation, Stanford University School of Medicine,